Mapping the Synaptome in Neurodegeneration: Emerging Clinical Applications of SV2A PET Imaging. [PDF]
Filippi L, Nuvoli S, Spanu A, Palumbo B.
europepmc +1 more source
Sleep differentially modulates synaptic vesicle protein 2A and spine density across cortical regions and development. [PDF]
Ma J +17 more
europepmc +1 more source
Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma. [PDF]
Barron T +31 more
europepmc +1 more source
New-Generation Antiseizure Medications: Who Takes the Lead in the Real World? [PDF]
Taraschenko O.
europepmc +1 more source
Sleep deprivation increases levels of the synaptic density marker SV2A in the human brain. [PDF]
Elmenhorst D +11 more
europepmc +1 more source
Psilocybin's effect on human brain synaptic plasticity. [PDF]
Johansen A +16 more
europepmc +1 more source
Detection of Focal Lesions in Epilepsy with [<sup>18</sup>F]UCB-H Synaptic Vesicle Protein 2A PET Imaging. [PDF]
Pakula V +15 more
europepmc +1 more source
Transcriptomic signatures of synaptic loss in Alzheimer's disease. [PDF]
Sun L +14 more
europepmc +1 more source
SV2A PET Imaging Detects Severity-Dependent Synaptic Changes After Experimental Traumatic Spinal Cord Injury. [PDF]
Schrauwen C +9 more
europepmc +1 more source

